Samantha Salas
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Samantha Salas’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$10,170
Pharmacies billed $10,170 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 67) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
53 generic and 14 brand-name prescriptions · $10,170 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $9,177 | $765 |
| Atorvastatin | 12 | $85 | $7 |
Year by year
| 2024 | 67 | 26 | 0% (0) | 21% | $10,170 |
| 2023 | 104 | 31 | 0% (0) | 18% | $12,130 |
| 2022 | 143 | 44 | 0% (0) | 28% | $22,423 |
| 2021 | 130 | 36 | 0% (0) | 20% | $13,581 |
| 2020 | 11 | None | 0% (0) | None | $1,931 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Rosuvastatin | 18 | $386 | $21 |
| Clopidogrel | 11 | $211 | $19 |
| Levetiracetam | 11 | $179 | $16 |
| Amlodipine Besylate | 11 | $73 | $7 |
| Hydrochlorothiazide | 12 | $13 | $1 |
2022: 5 drugs
| Eliquis | 21 | $11,546 | $550 |
| Xarelto | 13 | $6,433 | $495 |
| Rosuvastatin | 41 | $582 | $14 |
| Clopidogrel | 11 | $134 | $12 |
| Amlodipine Besylate | 15 | $42 | $3 |
2021: 4 drugs
| Eliquis | 12 | $6,258 | $521 |
| Xarelto | 12 | $5,863 | $489 |
| Rosuvastatin | 49 | $751 | $15 |
| Amlodipine Besylate | 16 | $52 | $3 |
Money from drug and device companies
$18 in 2025
| 2025 | 1 | 1 | None | $18 |
| 2024 | 1 | 2 | None | $31 |
| 2023 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Glassia | $18 | 1 payment
|
See the published payment
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-01 | Glassia | $18 |
See earlier years (2024, 2023)
2024: $31
| Takeda Pharmaceuticals U.S.A. | Glassia | $31 | 2 payments
|
2023: $14
| Takeda Pharmaceuticals U.S.A. | Aralast | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346850773
- Licence
- CA 95025473
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2020-07-31
- NPI last updated
- 2023-06-26
- NPI record certified
- 2023-06-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 20 York St, New Haven, CT, 06510
This office lists an electronic records connection.